Reports Library Publication
Cough, Cold & Allergy: Unpicking the CCA market’s prospects in an altered world
19th July 2022 by Nicholas Hall Reports
Covering all the issues affecting the CCA market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report spans 10 in-depth country profiles (plus shorter profiles of selected markets) with insights and predictions.
With launch activity in CCA slowing, has the impetus shifted from quantity to quality? New product developments are explored across markets, including Rx-to-OTC switches, delivery format innovations, new benefits and more.
Brand case studies evaluate the key lessons to be learned from top brands, including consumer messaging, line extensions, portfolio development and brand strategies.
The report features the latest sales data from our dedicated DB6 database, including topline historical sales by region, country and category, and individual brand performances.
Order this report
Pre-order your copy of the CCA report today.
Why buy this report?
"2021 saw Cough, Cold & Allergy sales return to positive growth (+4.4%) after successive periods of decline following a historic low-level incidence of colds & flu.
This report explores what is next for the CCA market – with sales having improved as more viruses circulate among the population, demand remains below that of peak pre-pandemic levels."Nicholas Hall